| Michael M. Monson, O.d., P.c. | |
|
1221 Dewey Blvd, Butte, MT 59701-3413 | |
| (406) 494-2222 | |
| (406) 494-2263 |
| Full Name | Michael M. Monson, O.d., P.c. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1221 Dewey Blvd, Butte, Montana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063622496 | NPI | - | NPPES |
| 000084143 | Other | MCR GROUP # | |
| DB 9976 | Other | MT | RR MCR # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 757 (Montana) | Primary |
| Provider Name | Michael Mark Monson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1205927175 PECOS PAC ID: 5799758389 Enrollment ID: I20040812001229 |
News Archive
The Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a Phase Ib/II study of bendamustine (Treanda®), an anticancer agent currently approved for the treatment of chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin's lymphoma (NHL), in combination with lenalidomide (Revlimid®) and dexamethasone in patients with relapsed multiple myeloma. The trial, led by Shaji Kumar, MD, of Mayo Clinic, is open for enrollment at Mayo Clinic (Rochester, Minn.), City of Hope Cancer Center (Duarte, Calif.) and the University of Chicago (Chicago, Ill).
Researchers of the Fraunhofer Institute for Molecular Biology and Applied Ecology IME have developed software for Germany that calculates the concentration of pesticides/plant protection products in surface waters like ditches or streams. The new process can be employed as a component of pesticide authorization procedures.
Russian physicists have developed a method for drastically narrowing the emission spectrum of an ordinary diode laser, like that in a laser pointer. This makes their device a useful replacement for the more complex and expensive single-frequency lasers, enabling the creation of compact chemical analyzers that can fit into a smartphone, cheap lidars for self-driving cars, as well as security and structural health monitoring systems on bridges, gas pipelines, and elsewhere.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of a new lung cancer test, Clarient Insight® Dx Pulmotype® Test, that helps physicians classify specific types of lung cancer to identify which therapies may be most effective.
Menopausal women with non-alcoholic fatty liver disease (NAFLD) who don't consume enough of the essential nutrient choline appear to be at higher risk for liver scarring, according to research led by scientists at Johns Hopkins Children's Center.
› Verified 6 days ago
| Provider Name | Cody Philip Blom |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1265026033 PECOS PAC ID: 6608282546 Enrollment ID: I20210301002618 |
News Archive
The Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a Phase Ib/II study of bendamustine (Treanda®), an anticancer agent currently approved for the treatment of chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin's lymphoma (NHL), in combination with lenalidomide (Revlimid®) and dexamethasone in patients with relapsed multiple myeloma. The trial, led by Shaji Kumar, MD, of Mayo Clinic, is open for enrollment at Mayo Clinic (Rochester, Minn.), City of Hope Cancer Center (Duarte, Calif.) and the University of Chicago (Chicago, Ill).
Researchers of the Fraunhofer Institute for Molecular Biology and Applied Ecology IME have developed software for Germany that calculates the concentration of pesticides/plant protection products in surface waters like ditches or streams. The new process can be employed as a component of pesticide authorization procedures.
Russian physicists have developed a method for drastically narrowing the emission spectrum of an ordinary diode laser, like that in a laser pointer. This makes their device a useful replacement for the more complex and expensive single-frequency lasers, enabling the creation of compact chemical analyzers that can fit into a smartphone, cheap lidars for self-driving cars, as well as security and structural health monitoring systems on bridges, gas pipelines, and elsewhere.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of a new lung cancer test, Clarient Insight® Dx Pulmotype® Test, that helps physicians classify specific types of lung cancer to identify which therapies may be most effective.
Menopausal women with non-alcoholic fatty liver disease (NAFLD) who don't consume enough of the essential nutrient choline appear to be at higher risk for liver scarring, according to research led by scientists at Johns Hopkins Children's Center.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael M. Monson, O.d., P.c. 1221 Dewey Blvd, Butte, MT 59701-3413 Ph: (406) 494-2222 | Michael M. Monson, O.d., P.c. 1221 Dewey Blvd, Butte, MT 59701-3413 Ph: (406) 494-2222 |
News Archive
The Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a Phase Ib/II study of bendamustine (Treanda®), an anticancer agent currently approved for the treatment of chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin's lymphoma (NHL), in combination with lenalidomide (Revlimid®) and dexamethasone in patients with relapsed multiple myeloma. The trial, led by Shaji Kumar, MD, of Mayo Clinic, is open for enrollment at Mayo Clinic (Rochester, Minn.), City of Hope Cancer Center (Duarte, Calif.) and the University of Chicago (Chicago, Ill).
Researchers of the Fraunhofer Institute for Molecular Biology and Applied Ecology IME have developed software for Germany that calculates the concentration of pesticides/plant protection products in surface waters like ditches or streams. The new process can be employed as a component of pesticide authorization procedures.
Russian physicists have developed a method for drastically narrowing the emission spectrum of an ordinary diode laser, like that in a laser pointer. This makes their device a useful replacement for the more complex and expensive single-frequency lasers, enabling the creation of compact chemical analyzers that can fit into a smartphone, cheap lidars for self-driving cars, as well as security and structural health monitoring systems on bridges, gas pipelines, and elsewhere.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of a new lung cancer test, Clarient Insight® Dx Pulmotype® Test, that helps physicians classify specific types of lung cancer to identify which therapies may be most effective.
Menopausal women with non-alcoholic fatty liver disease (NAFLD) who don't consume enough of the essential nutrient choline appear to be at higher risk for liver scarring, according to research led by scientists at Johns Hopkins Children's Center.
› Verified 6 days ago
Dr. Brandt Dennehy, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2410 Amherst Ave, Butte, MT 59701 Phone: 406-494-6692 Fax: 406-494-2205 | |
Dr. Anthony Lee Baumgartner, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 800 Sampson St, Butte, MT 59701 Phone: 406-494-1700 Fax: 406-494-1040 | |
Dr. Cody Philip Blom, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1221 Dewey Blvd, Butte, MT 59701 Phone: 406-494-2222 | |
Dr. Richard John Mitchell, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 3901 Harrison Ave, Butte, MT 59701 Phone: 406-494-0805 Fax: 406-494-0806 | |
Kristopher Sherrill, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3417 Busch St, Butte, MT 59701 Phone: 406-494-3145 | |
American Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1313 Harrison Ave, Butte, MT 59701 Phone: 406-782-2359 |